The Zacks Analyst Blog Highlights: BioMarin, Prosensa, Five Prime Therapeutics, AbbVie, Amgen, Biogen and Vertex
AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study
Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Astellas announces termination of Amgen-sponsored clinical studies of rilotumumab in gastric cancer (pdf 76.0KB)
Amgen ends studies of gastric cancer drug
Amgen ends studies of gastric cancer drug
JANA Partners opens a stake in Amgen
Amgen Ends Trials of Stomach-Cancer Therapy
Amgen Surprise, Discontinues Stomach Cancer Drug Study
Amgen ends trials of stomach-cancer therapy
Amgen Stops Gastric-Cancer Drug Trials on Increase in Deaths
Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
Amgen scraps trials of drug for advanced stomach cancer
Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
Motley Fool: Pundits pandering your wealth away
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia
Fighting kids' cancer... fixing a broken system
New data fuels doctors' demands to rewrite U.S. heart guidelines
SINGAPORE PRESS-Amgen opens S$200 mln plant in Singapore-Straits Times
Amgen Opens Next-generation Biomanufacturing Facility in Singapore
Why Amgen, Inc. Stock Surged 15% in October
Amgen Surprise, Discontinues Stomach Cancer Drug Study
Amgen Ends Trials of Stomach-Cancer Therapy
Amgen Inc, AstraZeneca's (AZN) Plaque Psoriasis Treatment Produces Positive ...
Mixed Readings For Biotech Short Interest
Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin ...
Amgen Shares Consolidating Ahead Of More Gains?
How Amgen Makes Billions On Just A Few Drugs
Amgen (AMGN) And AstraZeneca's (AZN) Psoriasis Drug Beats Johnson ...
Amgen (AMGN) Hits New Lifetime High
